Advertisement

Ads Placeholder
Loading...

SNDL Inc.

SNDLNASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$1.36
$0.03(2.26%)
U.S. Market opens in 0h 27m

SNDL Inc. (SNDL) Stock Overview

Explore SNDL Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap352.5M
P/E Ratio-31.66
EPS (TTM)$-0.04
ROE-0.01%
Fundamental Analysis

AI Price Forecasts

1 Month$1.36
3 Months$1.54
1 Year Target$2.02

SNDL Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of SNDL Inc. (SNDL) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 40.58, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $2.02.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -31.66 and a market capitalization of 352.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
2.26%
5-Day Change
3.03%
1-Month Change
-11.11%
3-Month Change
-21.84%
6-Month Change
-47.29%
Year-to-Date (YTD) Change
-21.84%
1-Year Change
-4.23%
3-Year Change
-14.47%
5-Year Change
-87.29%
All-Time (Max) Change
-98.40%

Contact Information

14039485227
919–11 Avenue SW, Calgary, AB, T2R 1P3

Company Facts

26,040 Employees
IPO DateAug 1, 2019
CountryCA
Actively Trading

Frequently Asked Questions